These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27856796)

  • 1. Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals.
    Bellinger AM; Jafari M; Grant TM; Zhang S; Slater HC; Wenger EA; Mo S; Lee YL; Mazdiyasni H; Kogan L; Barman R; Cleveland C; Booth L; Bensel T; Minahan D; Hurowitz HM; Tai T; Daily J; Nikolic B; Wood L; Eckhoff PA; Langer R; Traverso G
    Sci Transl Med; 2016 Nov; 8(365):365ra157. PubMed ID: 27856796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient weapon for protracted warfare to malaria: A chondroitin sulfate derivates-containing injectable, ultra-long-lasting meshy-gel system.
    Luo J; Zhang P; Liu R; Li X; Hua P; Li S; Zhang T; Zhang T; Fu Y; Song X; Gong T; Zhang Z
    Carbohydr Polym; 2019 Jun; 214():131-141. PubMed ID: 30925981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form.
    Altreuter DH; Kirtane AR; Grant T; Kruger C; Traverso G; Bellinger AM
    Expert Opin Drug Deliv; 2018 Dec; 15(12):1189-1198. PubMed ID: 30392404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral, Slow-Release Ivermectin: Biting Back at Malaria Vectors.
    Chaccour CJ; Rabinovich NR
    Trends Parasitol; 2017 Mar; 33(3):156-158. PubMed ID: 28065670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages.
    Kobylinski KC; Sylla M; Chapman PL; Sarr MD; Foy BD
    Am J Trop Med Hyg; 2011 Jul; 85(1):3-5. PubMed ID: 21734116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivermectin: a complimentary weapon against the spread of malaria?
    Alout H; Foy BD
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):231-240. PubMed ID: 27960597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scalable Gastric Resident Systems for Veterinary Application.
    Hayward A; Bensel T; Mazdiyasni H; Rogner J; Kirtane AR; Lee YL; Hua T; Bajpayee A; Collins J; McDonnell S; Cleveland C; Lopes A; Wahane A; Langer R; Traverso G
    Sci Rep; 2018 Aug; 8(1):11816. PubMed ID: 30087406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices.
    Zhang S; Bellinger AM; Glettig DL; Barman R; Lee YA; Zhu J; Cleveland C; Montgomery VA; Gu L; Nash LD; Maitland DJ; Langer R; Traverso G
    Nat Mater; 2015 Oct; 14(10):1065-71. PubMed ID: 26213897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroretentive inorganic-organic hybrids to improve class IV drug absorption.
    Perioli L; Pagano C
    Int J Pharm; 2014 Dec; 477(1-2):21-31. PubMed ID: 25290811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New antimalarial sustained-release formulations based on bioresorbable polymers: therapeutic evaluation using the Plasmodium berghei model].
    Tsakala M; Gillet J; Gillard J
    J Pharm Belg; 1990; 45(1):5-11. PubMed ID: 2185357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment.
    Verma M; Vishwanath K; Eweje F; Roxhed N; Grant T; Castaneda M; Steiger C; Mazdiyasni H; Bensel T; Minahan D; Soares V; Salama JAF; Lopes A; Hess K; Cleveland C; Fulop DJ; Hayward A; Collins J; Tamang SM; Hua T; Ikeanyi C; Zeidman G; Mule E; Boominathan S; Popova E; Miller JB; Bellinger AM; Collins D; Leibowitz D; Batra S; Ahuja S; Bajiya M; Batra S; Sarin R; Agarwal U; Khaparde SD; Gupta NK; Gupta D; Bhatnagar AK; Chopra KK; Sharma N; Khanna A; Chowdhury J; Stoner R; Slocum AH; Cima MJ; Furin J; Langer R; Traverso G
    Sci Transl Med; 2019 Mar; 11(483):. PubMed ID: 30867322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition from endemic behavior to eradication of malaria due to combined drug therapies: An agent-model approach.
    Sequeira J; Louçã J; Mendes AM; Lind PG
    J Theor Biol; 2020 Jan; 484():110030. PubMed ID: 31568789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-malarial drug formulations and novel delivery systems: a review.
    Murambiwa P; Masola B; Govender T; Mukaratirwa S; Musabayane CT
    Acta Trop; 2011 May; 118(2):71-9. PubMed ID: 21439929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the action of ivermectin on blood-sucking mosquitoes].
    Iakubovich VIa; Zakharova NF; Alekseev AN; Alekseev EA
    Med Parazitol (Mosk); 1989; (3):60-4. PubMed ID: 2571066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin and malaria control.
    Ōmura S; Crump A
    Malar J; 2017 Apr; 16(1):172. PubMed ID: 28438169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral controlled release dosage forms].
    Mehuys E; Vervaet C
    J Pharm Belg; 2010 Jun; (2):34-8. PubMed ID: 20623984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria.
    Richards FO
    Malar J; 2017 Apr; 16(1):168. PubMed ID: 28438168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.